A mild sweet or fruity odor typically indicates nutritional ketosis from fat metabolism during weight loss, which is generally benign
Most clinical guidance recommends: At 3 months: A1c recheck (HbA1c reflects the prior 3-month average, making this the earliest timepoint for meaningful assessment of glycemic response), metabolic panel if any GI side effects were significant At 6 months: Full panel repeat A1c, CMP, lipids, CBC to document treatment response comprehensively Annually: Full panel plus thyroid function, B12, and any additional markers relevant to your individual health picture If you experience severe or persistent gastrointestinal side effects, signs of dehydration, unusual fatigue, or any concerning symptoms, kidney function should be rechecked without waiting for a scheduled interval
Key takeaways The FDA-approved starting dose of semaglutide for weight loss is 0.25 mg weekly, and the maximum dose of semaglutide for weight loss is 2.4 mg weekly
Weight loss can reduce symptoms and slow the progression of vein disease, but it cannot repair damaged valves